Unknown

Dataset Information

0

Local and regional staging of invasive breast cancer with sonography: 25 years of practice at MD Anderson Cancer Center.


ABSTRACT: At The University of Texas MD Anderson Cancer Center, we have used sonography (US) extensively for more than 2 decades to refine the local and regional staging of invasive breast cancer. Although magnetic resonance imaging is superior to all other imaging modalities in the measurement of the primary tumor and detection of additional foci of malignancy, in our experience US has shown sufficient accuracy in clinical practice to stage most invasive breast cancers. The exceptions are ill-defined tumors such as invasive lobular cancers and tumors in breasts containing extensive diffuse benign disease. An advantage of US is that multifocality or multicentricity can be confirmed via US-guided fine-needle aspiration within 15 minutes and the information shared immediately with the patient and the breast surgeon or medical oncologist. US has also proved indispensable in the evaluation of lymphatic spread because it can evaluate more nodal basins (e.g., the supraclavicular fossa and low neck) than magnetic resonance imaging can and because it can guide needle biopsy to confirm the status of any indeterminate node (including internal mammary nodes) within minutes.

SUBMITTER: Fornage BD 

PROVIDER: S-EPMC3903064 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Local and regional staging of invasive breast cancer with sonography: 25 years of practice at MD Anderson Cancer Center.

Fornage Bruno D BD  

The oncologist 20131205 1


At The University of Texas MD Anderson Cancer Center, we have used sonography (US) extensively for more than 2 decades to refine the local and regional staging of invasive breast cancer. Although magnetic resonance imaging is superior to all other imaging modalities in the measurement of the primary tumor and detection of additional foci of malignancy, in our experience US has shown sufficient accuracy in clinical practice to stage most invasive breast cancers. The exceptions are ill-defined tum  ...[more]

Similar Datasets

2012-04-30 | GSE28541 | GEO
2012-04-29 | E-GEOD-28541 | biostudies-arrayexpress
| S-EPMC6904523 | biostudies-literature
| S-EPMC4454458 | biostudies-literature
| EGAO00000000362 | EGA